Biogency Synext Lite Tablets

Држава: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

Biotin, Quantity: 723 microgram; chromium picolinate, Quantity: 64.4 microgram (Equivalent: chromium, Qty 8 microgram); Curcuma longa, Quantity: 120 mg (Equivalent: Curcuma longa, Qty 2.4 g); cyanocobalamin, Quantity: 7.8 microgram; folic acid, Quantity: 125 microgram; leucine, Quantity: 34 mg; nicotinamide, Quantity: 16 mg; nicotinic acid, Quantity: 100 mg; Piper nigrum, Quantity: 4 mg (Equivalent: Piper nigrum, Qty 200 mg); pyridoxine hydrochloride, Quantity: 300 microgram (Equivalent: pyridoxine, Qty 247 microgram); quercetin, Quantity: 123 mg; Reynoutria japonica, Quantity: 42 mg (Equivalent: Reynoutria japonica, Qty 4.2 g); riboflavin, Quantity: 761 microgram; ubidecarenone, Quantity: 30 mg; heavy magnesium oxide, Quantity: 33 mg (Equivalent: magnesium, Qty 19.9 mg)

Доступно од:

Biogency Pty Ltd

Фармацеутски облик:

Tablet, film coated

Састав:

Excipient Ingredients: maltodextrin; microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; crospovidone; povidone; silicon dioxide; magnesium stearate; purified water; Carnauba Wax; titanium dioxide; purified talc; brilliant blue FCF aluminium lake; macrogol 4000; polyvinyl alcohol; tartrazine aluminium lake

Пут администрације:

Oral

Терапеутске индикације:

Maintain/support energy production ; Anti-inflammatory/relieve inflammation ; Maintain/support cardiovascular system health ; Maintain/support healthy cardiovascular system function ; Maintain/support blood capillary health ; Maintain/support (state vitamin/mineral/nutrient) levels in the body

Резиме производа:

Visual Identification: ;

Статус ауторизације:

Listed

Датум одобрења:

2020-04-17